62 related articles for article (PubMed ID: 6364905)
1. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191.
Graybill JR; Kaster SR
Am Rev Respir Dis; 1984 Feb; 129(2):292-5. PubMed ID: 6364905
[TBL] [Abstract][Full Text] [Related]
2. Antifungal and antihepatotoxic effects of sepia ink extract against oxidative stress as a risk factor of invasive pulmonary aspergillosis in neutropenic mice.
Fahmy SR; Soliman AM; Ali EM
Afr J Tradit Complement Altern Med; 2014; 11(3):148-59. PubMed ID: 25371577
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis.
Ullmann I; Aregger A; Leib SL; Zimmerli S
Microbiol Spectr; 2022 Jun; 10(3):e0275321. PubMed ID: 35435756
[TBL] [Abstract][Full Text] [Related]
4. Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis.
Wurster S; Pantaleón García J; Albert ND; Jiang Y; Bhoda K; Kulkarni VV; Wang Y; Walsh TJ; Evans S; Kontoyiannis DP
J Infect Dis; 2023 Apr; 227(7):901-906. PubMed ID: 36611269
[TBL] [Abstract][Full Text] [Related]
5. Genetic Analyses of Amphotericin B Susceptibility in
Fan Y; Korfanty GA; Xu J
J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682281
[No Abstract] [Full Text] [Related]
6. Brain glucose mediates amphotericin B tolerance.
Crunkhorn S
Nat Rev Drug Discov; 2024 Mar; 23(3):174. PubMed ID: 38326472
[No Abstract] [Full Text] [Related]
7. Susceptibility to Aspergillus Infections in Rats with Chronic Obstructive Pulmonary Disease via Deficiency Function of Alveolar Macrophages and Impaired Activation of TLR2.
Wu Y; Xu H; Li L; Yuan W; Zhang D; Huang W
Inflammation; 2016 Aug; 39(4):1310-8. PubMed ID: 27312383
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model.
White PL; Wiederhold NP; Loeffler J; Najvar LK; Melchers W; Herrera M; Bretagne S; Wickes B; Kirkpatrick WR; Barnes RA; Donnelly JP; Patterson TF
J Clin Microbiol; 2016 Apr; 54(4):960-6. PubMed ID: 26791366
[TBL] [Abstract][Full Text] [Related]
9. Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection.
Lengerova M; Kocmanova I; Racil Z; Hrncirova K; Pospisilova S; Mayer J; Najvar LK; Wiederhold NP; Kirkpatrick WR; Patterson TF
J Clin Microbiol; 2012 Mar; 50(3):602-8. PubMed ID: 22189110
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Vallor AC; Kirkpatrick WR; Najvar LK; Bocanegra R; Kinney MC; Fothergill AW; Herrera ML; Wickes BL; Graybill JR; Patterson TF
Antimicrob Agents Chemother; 2008 Jul; 52(7):2593-8. PubMed ID: 18474582
[TBL] [Abstract][Full Text] [Related]
11. New guinea pig model of Cryptococcal meningitis.
Kirkpatrick WR; Najvar LK; Bocanegra R; Patterson TF; Graybill JR
Antimicrob Agents Chemother; 2007 Aug; 51(8):3011-3. PubMed ID: 17562797
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Kirkpatrick WR; Perea S; Coco BJ; Patterson TF
Antimicrob Agents Chemother; 2002 Aug; 46(8):2564-8. PubMed ID: 12121933
[TBL] [Abstract][Full Text] [Related]
13. Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis.
Roberts J; Schock K; Marino S; Andriole VT
Antimicrob Agents Chemother; 2000 Dec; 44(12):3381-8. PubMed ID: 11083644
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Oct; 44(10):2865-8. PubMed ID: 10991875
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
Kirkpatrick WR; McAtee RK; Fothergill AW; Loebenberg D; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2000 Mar; 44(3):780-2. PubMed ID: 10681359
[TBL] [Abstract][Full Text] [Related]
16. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B.
Denning DW; Warn P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2592-9. PubMed ID: 10543734
[TBL] [Abstract][Full Text] [Related]
17. Aspergillus fumigatus and aspergillosis.
Latgé JP
Clin Microbiol Rev; 1999 Apr; 12(2):310-50. PubMed ID: 10194462
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
George D; Miniter P; Andriole VT
Antimicrob Agents Chemother; 1996 Jan; 40(1):86-91. PubMed ID: 8787885
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
Patterson TF; Fothergill AW; Rinaldi MG
Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.
Colombo AL; McGough DA; Rinaldi MG
Mycopathologia; 1994 Dec; 128(3):129-33. PubMed ID: 7739726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
